Steven Wheen
Stock Analyst at Jarden
(3.83)
# 1,894
Out of 4,600 analysts
232
Total ratings
45.4%
Success rate
8.1%
Average return
Main Sectors:
Stocks Rated by Steven Wheen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Maintained: Buy | $45.20 → $47.60 | $43.55 | +9.30% | 27 | Jul 29, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $21.80 → $21.10 | $14.72 | +43.34% | 30 | Jul 22, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $42.70 → $40.20 | $31.39 | +28.07% | 22 | Jul 8, 2026 | |
| ASX: REG Regis Healthcare Limited | Downgraded: Hold | $8.50 → $7.50 | $6.36 | +17.92% | 16 | Jun 18, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $21.90 → $22.30 | $22.25 | +0.22% | 29 | Jun 15, 2026 | |
| ASX: HLS Healius Limited | Maintained: Sell | $0.77 → $0.47 | $0.41 | +14.63% | 32 | May 14, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $244.00 → $191.00 | $130.66 | +46.18% | 33 | May 12, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $224.00 → $169.00 | $122.00 | +38.52% | 16 | Apr 22, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.35 → $3.25 | $2.22 | +46.40% | 23 | Feb 25, 2026 | |
| ASX: QUB Qube Holdings Limited | Maintained: Hold | $5.00 | $5.11 | -2.15% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22.00 | $24.61 | -10.61% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.75 | $0.56 | n/a | 2 | Nov 27, 2024 |
Ramsay Health Care Limited
Jul 29, 2026
Maintained: Buy
Price Target: $45.20 → $47.60
Current: $43.55
Upside: +9.30%
Telix Pharmaceuticals Limited
Jul 22, 2026
Maintained: Buy
Price Target: $21.80 → $21.10
Current: $14.72
Upside: +43.34%
ResMed Inc.
Jul 8, 2026
Maintained: Buy
Price Target: $42.70 → $40.20
Current: $31.39
Upside: +28.07%
Regis Healthcare Limited
Jun 18, 2026
Downgraded: Hold
Price Target: $8.50 → $7.50
Current: $6.36
Upside: +17.92%
Sonic Healthcare Limited
Jun 15, 2026
Maintained: Hold
Price Target: $21.90 → $22.30
Current: $22.25
Upside: +0.22%
Healius Limited
May 14, 2026
Maintained: Sell
Price Target: $0.77 → $0.47
Current: $0.41
Upside: +14.63%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $244.00 → $191.00
Current: $130.66
Upside: +46.18%
Cochlear Limited
Apr 22, 2026
Maintained: Hold
Price Target: $224.00 → $169.00
Current: $122.00
Upside: +38.52%
Integral Diagnostics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $3.35 → $3.25
Current: $2.22
Upside: +46.40%
Qube Holdings Limited
Feb 20, 2026
Maintained: Hold
Price Target: $5.00
Current: $5.11
Upside: -2.15%
Feb 20, 2026
Maintained: Hold
Price Target: $22.00
Current: $24.61
Upside: -10.61%
Nov 27, 2024
Maintained: Hold
Price Target: $0.71 → $0.75
Current: $0.56
Upside: n/a